Sarasin & Partners LLP, a registered investment adviser, initiated a new position in Amgen Inc. (NASDAQ:AMGN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 655,511 shares of the Healthcare company, valued at approximately $214,555,313 as of the filing date.
Amgen Inc.'s stock currently trades at $338.93 with a market capitalization of $170,905,687,765.